By proceeding, you agree to our Terms of Use and Privacy Policy.
Taking place in person for the first time this summer, the 3rd Annual Epigenetic-Targeted Drug Discovery & Development Summit is the first and only devoted industry-specific forum exclusively focused on showcasing the latest research and pre-clinical and translational development of small-molecule, and other epigenetic modulators of gene expression
Learn about the latest research and pre-clinical and translational developments of small-molecule, and other epigenetic modulators of gene expression.
Understand the latest progress on DNA methylation, histone post-translational modifications, chromatin remodeling, and non-coding RNAs (ncRNAs) for cancer therapies.
Hear from Research Experts and Scientific Officers from Epizyme, University of San Diego California, Dana Farber Cancer Institute, Dewpoint Therapeutics and more.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Epigenomics is the systematic analysis of the global state of gene expression not attributable to mutational changes across the entire genome.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.